Spero Ventures
VC Fund
Redwood City, United States
Spero Ventures is a VC fund in Redwood City focused on Software and Internet. Spero Ventures makes venture investments in the things that make life worth living - wellbeing; sustainability; learning, work, and play.
- Total investments:
- 70
- Last investment:
- Lead investor:
- 50%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Spero Ventures invests in
Stages Spero Ventures invests in
Countries Spero Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 6 contacts → | |||
Round size
- Seed
- $2.4M–$10M
- Series A
- $7.5M–$21M
Investment Focus
Industry
- Software 14 (20%)
- Internet 8 (11%)
- Artificial Intelligence 8 (11%)
- Education 6 (9%)
- Health Care 6 (9%)
Stage
- Series A 26 (37%)
- Seed 20 (29%)
- Funding Round 5 (7%)
- Venture - Series Unknown 5 (7%)
- Series B 3 (4%)
Country
- United States 42 (60%)
- Israel 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Andrew Parker
General Partner
|
General Partner | Total investments: 34 | Find email | |
|
Brandon Walker
Investor
|
Investor | Total investments: 0 | Find email | |
Marc Tarpenning
Venture Partner
|
Venture Partner | Total investments: 16 | Find email | |
Sara Eshelman
Principal
|
Principal | Total investments: 7 | Find email | |
Shripriya Mahesh
Co-Founder and General Partner
|
Co-Founder and General Partner | Total investments: 10 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Tiny Health is the leading microbiome health platform for people tackling chronic conditions or looking to optimize overall health. Tiny Health’s Gut Health Test is the first-ever at-home gut microbiome test for pregnant moms and babies to use shotgun metagenomics, and the company now also offers tests for older children and adults, as well asVaginal Health Tests.To date, 30,000 families have trusted Tiny Health to correct imbalances in the gut and vaginal microbiome, and optimize their lifelong health. By taking evidence-based action steps from a dietary, supplement and lifestyle based on personalized results, we've helped people reduce severe symptoms and in some cases even reverse chronic conditions. Tiny Health's team includes top scientists, physicians, and microbiologists from Mayo Clinic, Johns Hopkins, Stanford, WashU, Cornell, and Harvard Medical School. For more information, visit tinyhealth.com and poweredbytiny.com | $33M / Series B / Sep 29, 2026 | ||
| Corvus Robotics make indoor drones for warehouses Inventorying. They provide an advanced inventory & inspection solution for warehouse and manufacturing facilities. | $20M / Venture - Series Unknown / Aug 25, 2026 | ||
| AGent Energy operates a hardware and software platform that connects commercial, industrial, and institutional backup generators and other distributed energy resources to electricity markets. The company installs onsite equipment and software, monitors generator condition and utilization, and manages participation in demand-response and other gridprograms. Its platform supports remote dispatch, operational alerts, anomaly detection, compliance processes, and diagnostic data for facilities such as hospitals, manufacturers, data centers, universities, agricultural sites, retailers, and water infrastructure operators. AGent Energy shares market proceeds with participating facility owners while maintaining generator availability for backup use. | $11M / Seed / Aug 13, 2026 | ||
| Sora Fuel makes jet fuel from just air, water, and renewable energy. Sora Fuel combine carbon capture and utilization into a single process, dramatically reducing the amount of energy required to produce SAF, enabling a truly affordable, carbon-negative drop-in solution. | $14.6M / Venture - Series Unknown / Apr 08, 2026 | ||
| Mobius Materials develops and supplies advanced silicon-based materials designed to improve performance and efficiency in energy storage and semiconductor applications. The company’s core technology focuses on producing high-purity silicon materials engineered for use in lithium-ion battery anodes, where they help increase energy density and extendbattery life compared to conventional graphite-based solutions. Its materials are designed to integrate into existing battery manufacturing processes, supporting adoption without requiring major changes to production infrastructure. Mobius Materials also applies its silicon processing capabilities to specialty materials used in electronics and semiconductor manufacturing, addressing applications that require precise material properties and consistency. The company supports customers through material development, testing, and collaboration aimed at optimizing performance for specific use cases. Its offerings are used by organizations working on next-generation batteries and electronic components that require improved capacity, durability, and material efficiency. | $3M / Seed / Dec 12, 2025 | ||
| Pickaxe allows non-technical creative professionals to test prompts, deploy them as tools at scale, and continuously improve their tools through real-time monitoring. | $3.8M / Seed / Sep 16, 2025 | ||
| Euclid Power operates in the renewable energy sector, providing a comprehensive platform for project management, investment, and execution. The company offers data-driven solutions that span from project development to asset management. Euclid Power's platform is designed to simplify the process of renewable energy project development andexecution. | $20M / Series A / Sep 05, 2025 | ||
| Wattch is a software development company that offers scalable energy data analytics platforms for the renewable energy industry. It enables observability, intelligence, and control for any renewable energy system. | $6M / Seed / Aug 05, 2025 | ||
| Remark is a product guidance startup for online stores that brings the in-store experience online. | $16M / Series A / Jul 01, 2025 | ||
| Persist assist pharmaceutical companies in developing long-acting formulations 50% faster. Because the formulation development process is manual and relies on scientific intuition, it takes a pharmaceutical company 5-10 years to develop a long acting formulation for a drug. This effort is divided into five years of pre-clinical development and fiveyears of clinical testing. Their goal is to use machine learning and automation to reduce the time required for pre-clinical formulation development to three months, making the formulation development process 50% faster. | $12M / Series A / Mar 19, 2025 | ||
| See all 70 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Spero Ventures invest in?
Spero Ventures invests primarily in Software, Internet and Artificial Intelligence startups, most often at Series A and Seed stage. Most of the 70 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Spero Ventures invest in?
Spero Ventures typically joins rounds of $2.4M–$10M at Seed and $7.5M–$21M at Series A. These are whole funding-round sizes, not Spero Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Spero Ventures took part in.
How do I contact Spero Ventures?
Public channels for Spero Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Spero Ventures?
The team at Spero Ventures includes Andrew Parker (General Partner), Brandon Walker (Investor) and Marc Tarpenning (Venture Partner), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
